Results 271 to 280 of about 791,464 (334)

Exploring the Vasculitis‐Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications

open access: yesAdvanced Science, Volume 13, Issue 14, 9 March 2026.
This review outlines association between vasculitis and malignancies and provides practical value for clinicians in distinguishing primary vasculitis from malignancy‐associated forms and optimizing patient surveillance, improving recognition of tumor‐associated vasculitis to reduce the risk of misdiagnosis, supporting more accurate clinical decision ...
Xiaofei Shi   +8 more
wiley   +1 more source

A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
Etoposide mediated topoisomerase II inhibition in Cervical Cancer. ABSTRACT Background Etoposide is a semisynthetic derivative of podophyllotoxin and an FDA‐approved topoisomerase II inhibitor that induces DNA strand breaks leading to cancer cell death.
Nikitha Kotian   +3 more
wiley   +1 more source

Symptom Clusters and Symptom Burden in Cancer Survivors

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Context Limited information is available on the symptom burden and symptom clusters in cancer survivors. Objectives Describe the occurrence, severity, and distress of 44 symptoms; determine risk factors associated with a higher symptom burden; and evaluate for symptom clusters using symptom occurrence rates.
Marilyn J. Hammer   +12 more
wiley   +1 more source

Survival Trends and Prognostic Modeling in ALK‐Positive Anaplastic Large Cell Lymphoma: A Population‐Based Study in the Brentuximab Vedotin Era

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background ALK‐positive anaplastic large cell lymphoma (ALK+ ALCL) is a rare subtype of peripheral T‐cell lymphoma with traditionally favorable prognosis. The introduction of brentuximab vedotin (BV) has significantly impacted treatment outcomes, but the long‐term survival trends and predictive factors for this population remain underexplored.
Qiuyu Zhang, Yanyan Liu
wiley   +1 more source

Breathless and Beyond: Anterior Mediastinal Malignant Peripheral Nerve Sheath Tumor as a Rare Neurofibromatosis Type 1 Manifestation

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Malignant peripheral nerve sheath tumors (MPNSTs) can rarely present as anterior mediastinal masses in patients with neurofibromatosis type 1 (NF1), causing respiratory symptoms and diagnostic challenges. Multidisciplinary evaluation, including biopsy and imaging, is essential for diagnosis, with surgical resection as the primary treatment ...
Muhammad Hassan Raza   +8 more
wiley   +1 more source

A Rare Case of Cutaneous Mucormycosis by Syncephalastrum Species in a Patient With Diabetes Mellitus: A Case Report and Review of the Literature

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Infections caused by Syncephalastrum species in humans are relatively rare. However, clinicians must maintain a high suspicion for it in immunocompromised patients with cutaneous mucormycosis. Prompt histopathological and microbiological investigations, combined with timely antifungal therapy and surgical intervention, are crucial to prevent ...
Iqra Maryam   +6 more
wiley   +1 more source

Cutaneous Lymphoma

open access: yesAnnals of Oncology, 1999
openaire   +1 more source

Cutaneous lymphomas

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2007
SummaryCutaneous lymphomas are rare skin diseases. They must be differentiated from secondary skin infiltrates by primary nodal lymphomas. Primary cutaneous lymphomas can be classified into B‐ and T‐cell lymphomas and hematodermic neoplasms; they usually possess a favorable prognosis and run a chronic course. Treatment is dependent on stage.
Reinhard, Dummer   +2 more
openaire   +4 more sources

Cutaneous Lymphomas

Archives of Dermatology, 2009
International ...
Seçkin, D, Hofbauer, G F L
openaire   +4 more sources

Home - About - Disclaimer - Privacy